FDA Inspection 646935 — SpecGx LLC

SpecGx LLC — FEI 1317295

The FDA completed an inspection of SpecGx LLC on Jan 27, 2010 in Hobart, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 27, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hobart, NY (United States)

Citations

IDCFRDescription
115921 CFR 211.28(a)Clothing appropriate for duties performed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
356521 CFR 211.58Buildings not maintained in good state of repair
434021 CFR 211.142Written warehousing procedures established/followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.